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Abstract 
Objective: Hyperexcitability of the central nervous system plays an important role in the 
development and maintenance of chronic pain in adults. This knowledge led to improved 
treatment strategies within this population. In children, however, research on the presence of 
central hyperexcitability is scarce. To further investigate this topic in children with chronic 
pain there is need for a clear literature overview.  
Design: Systematic review 
Methods: The literature search was performed using the electronic databases PubMed and 
Web of Science. An article was considered eligible if it included children (2-12 years old) 
diagnosed with chronic pain. Articles had to report original research outcomes related to 
central hyperexcitability and a comparison with a healthy control group was necessary. 
Characteristics of the study sample, the assessment and conclusions regarding central 
hyperexcitability were extracted from each included article.  
Results: Twelve case-control studies were included with moderate to good methodological 
quality (510 children with chronic pain and 670 healthy controls). After summarizing the 
articles’ results on indices of central hyperexcitability, we concluded that secondary 
hyperalgesia might be present in children with recurrent abdominal pain, juvenile 
fibromyalgia and juvenile idiopathic arthritis. Preliminary evidence exists for altered cortical 
nociceptive processing in children with migraine and recurrent abdominal pain.  
Conclusions: Based on the results of this review, central hyperexcitability might be present in 
in several pediatric chronic pain conditions. Further research on other manifestations of 
central hyperexcitability (e.g. bottom-up and top-down mechanisms and nociceptive brain 
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changes) are necessary to provide firm evidence about its presence in children with chronic 
pain.  
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Introduction 
Chronic pain, generally defined as continuous or recurrent pain episodes lasting more than 12 
weeks, or pain that persists beyond the normal expected time for tissue healing, is a common 
problem in children and adolescents(1). Prolonged pain can be disease-related, may occur 
post injury or can be idiopathic, arising spontaneously or from an obscure or unknown cause. 
Prevalence rates of chronic pediatric pain are generally higher in girls, increase with age and 
range substantially in community surveys (e.g., headache: 8-83%; abdominal pain: 4-53%; 
back pain: 14-24%; musculoskeletal pain: 4-40%)(1,2). Chronic pediatric pain is reported to 
be distressing and in severe cases prolonged pain may even severely debilitate and affect the 
children’s overall quality of life(3). In addition, previous research reported that children with 
a history of childhood chronic pain show a greater predisposition to persistent pain and are 
more likely to develop new and different types of pain into adulthood(4,5). 
The pathophysiology of chronic pain is complex and can be partly explained by an interaction 
between primary afferent nerves, dorsal horn neurons, spinal glia, neurotransmitters and other 
factors that transit and perpetuate the symptoms of chronic pain(3). Awareness is growing that 
central hyperexcitability may be of prime importance in the development, persistence and 
management of chronic pain(6). Central hyperexcitability refers to an increased 
responsiveness of nociceptive neurons in the central nervous system to their normal or 
subthreshold afferent input (i.e. central sensitization)(7). This process encompasses 
malfunctioning of descending inhibitory nociceptive pathways,  increased activity of 
facilitatory nociceptive pathways and altered neuronal synapses in the brain(8–11). 
Central hyperexcitability can manifest itself as an increased responsiveness to a variety of 
stimuli including mechanical pressure, chemical substances, cold temperature, heat 
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temperature and electrical stimuli(11–14). Since different mechanisms contribute to central 
hyperexcitability as mentioned above, it is challenging for researchers to measure central 
hyperexcitability. This may explain the absence of a true gold standard measurement for the 
assessment of central hyperexcitability in human subjects(15). Therefore, clinical or 
neurophysiological manifestations are assessed by different methods such as quantitative 
sensory testing, algometry, generalised hyperalgesia, wind-up, efficacy of endogenous 
analgesic control, etc. Outcomes are compared with healthy controls to provide information 
regarding the potential involvement of central hyperexcitability in chronic pain states.  
As mentioned above, central hyperexcitability is a form of maladaptive neuroplasticity(16). 
To date, there is increasing evidence for involvement of central hyperexcitability in many 
adult chronic pain conditions including rheumatoid arthritis, low back pain, osteoarthritis, 
fibromyalgia, chronic whiplash and gastrointestinal disorders(12,17–21). However, evidence 
about central hyperexcitability in adults should not be generalised to children. A major 
concern is the child’s different neuroplasticity in comparison to adults(22). Additionally, 
research has shown that differences in central pain modulation exist between children and 
adolescents(23) due to e.g. developmental changes in pain cognitions and emotions. 
Therefore, this review aims to investigate the existing literature on the presence and possible 
role of central hyperexcitability in children with chronic pain. If central hyperexcitability is 
present in certain chronic pediatric pain populations, then treatment programmes should be 
adapted accordingly. 
Methods 
A systematic search of the existing literature was done using the PRISMA guidelines(24).  
Eligibility Criteria  
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To be included in this systematic review articles had to meet the following inclusion criteria: 
(1) participants had to include children (aged 2-12 years), diagnosed with chronic or recurrent 
pain; (2) articles had to report on outcomes related to central hyperexcitability (pain 
thresholds, temporal summation, conditioned pain modulation, etc.), compared to a healthy 
control group. (3) The duration of pain was of great importance; according to the IASP 
definition of chronic pain, children had to have pain for at least 3 months(7). Articles 
involving patients with acute, postoperative or palliative pain were excluded. (4) Finally, the 
articles had to be full text reports or original research (no abstracts, case reports, reviews, 
meta-analysis, letters, expert opinions or editorials). All languages other than Dutch or 
English were excluded from this systematic literature search.  
Information sources and search   
A systematic search of the existing literature was performed using the electronic databases 
PubMed (http://www.ncbi.nlm.nih.gov/pubmed) and Web of Science 
(http://apps.webofknowledge.com). The last search was run on 9 October 2017. The search 
strategy was based on a combination of keywords and MESH terms and could be divided in 
three groups according “PICO”: (P1) chronic pain; (P2) in children and (O) a measure of 
central hyperexcitability (Table 1). Limits were applied for language (Dutch and English), 
species (Humans) and ages (Child, Preschool child). The complete search strategy for all 
databases is available as supplementary material (Appendix 1). 
Study selection  
Eligibility assessment was performed independently in a blinded standardized manner by 
three reviewers. All titles and abstracts were read to identify relevant articles. In addition, we 
scanned the reference lists of the selected articles. In case of uncertainty regarding the 
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eligibility of the article based on title and abstract or absence of the abstract, the full text 
version of the article was retrieved and evaluated against the inclusion criteria. The full text 
version of all articles that met the inclusion criteria were further examined on methodological 
quality and data extraction. 
Data collection process & data items   
A data extraction sheet was developed and completed independently by three researchers. 
Two researchers (A.F. & S.V.O.) used a specific template in Excel to screen all articles. 
Another researcher (R.P) used the software Rayyan, a web app for exploring and filtering 
searches for eligible studies(25). Disagreements between reviewers were resolved by 
discussion on a consensus meeting. If no consensus could be reached, a fourth researcher was 
consulted (M.M.). The selected articles were imported in the reference software EndNote and 
checked for duplicates.  
Information was extracted from each included article on: (1) characteristics of the study 
sample (including age, sex, disease), (2) the study sample’s inclusion criteria; (3) assessment 
and general conclusions regarding central hyperexcitability.  
Quality Assessment (Risk of bias)  
Risk of bias was assessed by three independent, blinded researchers who were not acquainted 
with each other’s evaluation of the search results before having a consensus meeting. After 
having rated the selected articles, the results of all researchers were compared and differences 
were analyzed and discussed. In case of a disagreement, another opinion was provided by a 
fourth researcher (M.M.). The methodological quality of the case-control studies was 
performed using the Newcastle-Ottawa Scale (NOS), which is recommended by the Cochrane 
Collaboration (http://www.cochrane.org). The NOS uses a star rating system to judge quality 
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based on three aspects of the study. A maximum of 9 stars can be awarded. No cut-off value 
of methodological quality was set for inclusion. Detailed information on the authors’ rating 
method of the NOS is available as supplementary material (Appendix 2). 
Results 
Study selection 
The selection process of the relevant papers is presented in Figure 1. The initial search using 
PubMed, Web of Science and hand-search of reference lists revealed 1379 papers after the 
removal of duplicates. The remaining articles were screened on title and abstract, resulting in 
179 articles for full-text screening. After this last screening, 12 articles remained for 
inclusion.  
Risk of bias  
The three researchers agreed in most cases on scoring the selected papers on risk of bias 
assessment. After a second review and discussing the discrepancies, the reviewers reached a 
consensus on all items. The definite consensus score and detailed information on the scores of 
methodological quality can be found in Table 2. The methodological quality was overall 
acceptable (the total number of stars varied between 3 and 7), with only one study scoring a 
total of 3 stars(26). Criterion 9 of the NOS, concerning the non-response rate was not 
evaluated, since not a single study described a follow-up period. All included studies were 
given a level of evidence B, since only case control studies were included(27).  
Study characteristics 
The main characteristics of the included studies are presented in Table 3. Studies on children 
with recurrent abdominal pain (RAP)(28–31), juvenile idiopathic arthritis (JIA)(26,32–34), 
migraine (MIG)(35,36), temporomandibular disorder (TMD)(37) and juvenile fibromyalgia 
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(FM)(38) were selected. In total 1180 children were included in this review, of which 510 
children presenting chronic pain and 670 healthy controls. More detailed information about 
the studies’ assessments on central hyperexcitability is available as supplementary material 
(Appendix 3). 
Indices of central hyperexcitability 
1. Pain thresholds  
Pressure pain thresholds (PPTs)  
Nine studies performed PPTs as part of their outcome measures(26,28–30,32,34,35,38,39). 
Different local and remote test sites were used, depending on the chronic pain population.  
Three studies examined PPTs in children with RAP. Two studies reported significant lower 
PPTs at all test sites when compared to healthy controls(28,29), while another study found the 
opposite(30).  
Five studies, assessing PPTs in children with JIA presented inconsistent findings. The 
majority of the studies showed significantly lower PPTs at all measured test 
points(26,32,34,39). Reid et al. found the opposite, showing no difference in PPTs in children 
with JIA when compared to healthy controls(38). The latter study also examined PPTs in 
children with juvenile FM and reported significantly lower PPTs at the test sites when 
compared to healthy controls. However, at the remote test sites only significant lower pain 
tolerance in children with juvenile FM could be found(38).  
One study investigated PPTs in children with MIG but found no differences compared with 
healthy controls(35).  
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In summary, moderate evidence was found for secondary mechanical hyperalgesia in children 
with RAP and JIA. Preliminary evidence has shown some potential for the presence of 
secondary hyperalgesia in children with juvenile FM and no evidence was found in children 
with MIG.  
Thermal thresholds (cold and heat pain thresholds) 
Three studies assessed thermal pain thresholds(26,31,36). All three studies examined those 
thresholds in a different population, though all used the thenar eminence as remote test site.  
Zohsel et al. found no lower heat pain thresholds compared to healthy controls, neither in 
children with MIG(36) nor in children with RAP(31).  
Another study examining both heat and cold pain thresholds in children with JIA showed the 
opposite. Both thresholds were lower at all test sites compared to healthy controls(26).  
In contrast to the preliminary evidence in children with JIA, no evidence for secondary 
thermal (hot and/or cold) hyperalgesia was found in children with MIG or RAP.  
Other measurements  
Jedel et al. examined the pain threshold in children with TMD, giving electrical stimulation 
between the thumb and the index finger. No significant difference was found compared to 
healthy controls, indicating preliminary evidence for the absence of secondary hyperalgesia in 
children with TMD. Two studies investigating the mechanical pain threshold in response to a 
set of seven standardized pinprick punctuate probes with a blunt tip, found significant lower 
thresholds in children with MIG(31) and RAP(31).   
2. Detection thresholds 
One study examined sensory detection thresholds in children with JIA(26). Both mechanical 
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and thermal detection thresholds (heat and cold) were significantly different compared to 
healthy controls; JIA patients were hypersensitive to mechanical stimuli, but hyposensitive to 
thermal stimuli (heat and cold). In children with JIA, a greater temperature change was 
required to perceive temperature. Similarly, the vibration detection thresholds were 
significantly lower compared to healthy controls, indicating hyposensitivity.  
Overall, preliminary evidence was found for secondary mechanical hypersensitivity in 
children with JIA and secondary hyposensitivity in response to thermal (heat and cold) and 
vibration stimuli.  
3. Temporal Summation of Pain  
Two studies examined the so-called “wind-up” phenomenon. Their first study was conducted 
in children with MIG. Nearly all participants showed signs of temporal summation at both test 
sites. However, no significant group differences were found(36). 
Their second study in children with RAP showed different results, depending on the test site. 
No significantly different response to repetitive noxious stimulation was found at the local test 
site. Still, at the remote site, children with RAP showed significantly decreased temporal 
summation compared to the control group(31).  
Preliminary evidence has shown some potential for the absence of increased activity of 
facilitatory nociceptive pathways in children with MIG and RAP.  
4. Thermal habituation  
Thermal habituation was examined in two studies(31,36). Less thermal habituation was seen 
at the remote test site in children with MIG, compared to healthy children(36). However, no 
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significant group differences were found. At the local test site, both groups of children 
showed thermal habituation, again not significantly different.  
Contrasting results were found in children with RAP(31). They showed more habituation in 
response to tonic heat at the remote test site compared to healthy children. Still, at the local 
test site, no significant group differences were found(31).  
In contrast to preliminary evidence in children with RAP, no explicit evidence for reduced 
thermal habituation was found in children with MIG.  
5. Altered cortical nociceptive processing    
Two studies evaluated cognitive aspects of nociceptive processing in children with RAP(30) 
or MIG(35), using electroencephalography. The authors concluded that chronic pain in 
children is associated with automatic attention to painful and potential painful stimuli, which 
may reflect difficulties in sufficient activation of pain-inhibiting processes(30,35). These 
preliminary findings suggest that altered cortical nociceptive processing, as a feature of 
central hyperexcitability, might be present in children with RAP and MIG.   
Discussion 
The goal of the present systematic literature search was to review the scientific literature 
addressing central hyperexcitability in children with chronic pain.  
Similar to research in adults(8,18,40,41), evidence for the presence of secondary hyperalgesia 
was found in children with JIA(26,32–34) and juvenile FM(38). Heterogeneity within the 
RAP and MIG population and modality-specific alterations in somatic pain sensitivity(42,43) 
might explain the inconsistent results regarding secondary hyperalgesia in children with RAP 
and MIG(28–31,36). Despite a recent study suggesting the role of generalized 
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hyperexcitabilty in the central processing of nociceptive input in the pathophysiology of 
TMD(44), secondary hyperalgesia could not be found in children(37).  
Besides pain and detection thresholds, advanced measurement techniques to assess 
descending inhibitory nociceptive pathways (conditioned pain modulation) and facilitatory 
nociceptive pathways (temporal summation or wind-up ratio) exist to gain clinical relevance 
in the evaluation of central hyperexcitability in both adults and children(45,46). This 
systematic review underlines the dearth of knowledge on the efficacy of these pathways in 
children with chronic pain(31,36). Although, inefficient endogenous nociceptive control is 
seen in various adult chronic pain populations(17,50–52). Moreover, research has shown that 
the efficiency of our descending inhibitory nociceptive pathways decreases with age(53). In 
light of the foregoing, the question arises how this system works in children. One study 
suggested that endogenous pain modulatory mechanisms of premature children are not as well 
developed as those of children not exposed to early pain at birth(54). However, alterations in 
this system might also occur in the context of chronic pain in children. One study investigated 
its efficacy and found deficient endogenous nociceptive control in girls with irritable bowel 
syndrome when comparing them to healthy controls(55).  This study was not included in this 
systematic review because it did not meet the inclusion criteria for pain duration (pain 
complaints > 3 months). Future research is warranted to confirm these preliminary results and 
to further investigate both pain inhibition and facilitation pathways in children with other 
chronic pain disorders. 
Additionally, research about the neuroplastic brain changes in relation to central 
hyperexcitability is lacking. Fortunately, multiple non-invasive structural and functional 
neuroimaging methods have been developed to enable rapid progress in understanding the 
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processing of pain in the human brain and to provide insight into the mechanisms underlying 
chronic pain(49).  
This systematic review has some limitations. Different diseases involving chronic pain were 
included, leading to a heterogeneous study population. Even when using the same test device, 
different protocols and different local and remote test sites were used to evaluate the presence 
of central hyperexcitability, possibly leading to different results. Both aspects hampered the 
formulation of a straightforward conclusion regarding the presence of central 
hyperexcitability in children with chronic pain in general.  
The large differences in protocol between the included studies reflect the need for a well 
validated device or procedure to measure central hyperexcitability. Efforts should be made to 
identify subgroups within the pain conditions in order to explain inconsistent results between 
studies investigating the same pain condition and similar manifestations of central 
hyperexcitability. It should be questioned why children with chronic pain present 
manifestations of central hyperexcitability, such as lowered PPTs. Three of four 
studies(26,32,33) in children with JIA suggested that the presence of secondary hyperalgesia 
might be the result of long-lasting nociceptive bombardment from inflamed joints, leading to 
peripheral and central hyperexcitability of nociceptive afferents. Still, studies investigating 
this causal relationship are necessary since most of the allegations are based on adult research. 
Given the plasticity of the child’s central nervous system, it might be hypothesized that 
changes in the central nervous system occur faster or more frequent in children with chronic 
pain when compared with adults.  
The presence of central hyperexcitability implies that the brain produces pain even when there 
is no apparent somatic nociceptive input(56). Thus, as part of the existing multidisciplinary 
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treatment(2), children with chronic pain might benefit from education about the cause of their 
pain, relevant pain mechanisms and the integral role of psychosocial and physical factors in 
precipitating and maintaining their pain(57). Research in various adult chronic pain 
populations has shown that his main content can be given by pain neuroscience education(58–
62). Future studies should investigate its positive values in children with chronic pain.  
Conclusions 
Based on the results of this review, central hyperexcitability might be present in children with 
RAP, JIA, juvenile FM and MIG. Still, substantial gaps in knowledge remain due to the 
varying methodologies of studies and mixed findings within disease groups. Research should 
further investigate whether changes in the child’s brain, endogenous pain modulation and pain 
facilitation as manifestations of central hyperexcitability are present in children with chronic 
pain disorders.   
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Figure 1. Flow chart of study selection according PRISMA guidelines 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-
Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed1000097 
Records identified through database searching 
(n =  1398 ) 
 PubMed (n=701); Web of Science (n=697) 
Additional records identified 
through other sources 
(n = 14 ) 
Records after duplicates removed 
(n = 1365) 
Records screened for title and abstract  
(n = 1379) 
Records excluded, with reasons 
(n = 1200 ) 
 Wrong population (622) 
 Wrong outcome (518) 
 Wrong study design (60) 
 
 Full-text articles assessed for eligibility 
(n = 179) 
Full-text articles excluded, with 
reasons (n = 167) 
 Wrong population (66): adults, 
adolescents (>12y), no chronic 
pain, no control group  
 Wrong outcome (51): no CS 
measurement, only primary 
hyperalgesia  
 Wrong study design (50): 
review, expert opinion, 
commentary, case report, 
editorial, conference paper, 
book 
 
 
Studies included in qualitative synthesis 
(n = 12) 
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Table 1. Keywords used to build the search strategy  
Database  Keywords  Additional filters  
(P1) 
Patient  
(P2) 
Problem 
(O) Outcome 
Pubmed Children 
Child  
Kid  
Infant  
Preschool  
Chronic pain  
Idiopathic 
pain  
Intractable 
pain  
Central nervous system 
sensitization  
Allodynia  
Hypersensitivity  
Hyperexcitability  
Hyperalgesia  
Pain facilitation  
Wind-up  
Temporal summation  
Long term potentiation  
Spatial summation  
Conditioned pain modulation  
Diffuse noxious inhibitory 
control  
Algometry  
Quantitative sensory testing  
Pain tolerance  
Pain threshold  
Pain perception  
Pain intensity  
Pain mechanism  
Pain dampening  
Humans 
Dutch  
English  
Child: 6-12y 
Preschool child: 
2-5y 
Web of 
Science 
No 
keywords  
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Table 2. Assessment of methodological quality with Newcastle-Ottawa Scale 
 
     
Study Year  
Selection  Comparability  Exposure  
No. of 
stars  
1 2 3 4 5 6 7 8 
Alfven et al.  1993   ★ ★ ★ ★   ★ ★ 6 
Cornelissen et al.  2014 ★ ★    ★       3 
Duarte et al.  2000 ★ ★  ★ ★ ★   ★ 6 
Hermann et al.  2008    ★ ★ ★ ★   ★ 5 
Hogeweg et al.  1995 ★     ★   ★ ★ 4 
Hogeweg et al.  1995 ★ ★    ★ ★ ★ ★ 6 
Jedel et  al.  2007   ★ ★ ★ ★ ★   ★ 6 
Leegaard et al.  2013 ★ ★ ★ ★ ★ ★   ★ 7 
Reid et al.  1997 ★ ★ ★   ★ ★   ★ 6 
Zohsel et al.  2006    ★ ★ ★ ★   ★ 5 
Zohsel et al.  2008    ★ ★ ★ ★   ★ 5 
Zohsel et al.  2008     ★ ★ ★ ★   ★ 5 
0: criterion not fulfilled; 1: criterion fulfilled,  
NOS: Newcastle-Ottowa Scale: Case -control studies 
Criterion 1: Is the case deifinition adequate 
Criterion 2: Representativeness of the cases  
Criterion 3: Selection of controls  
Criterion 4: Definition of controls  
Criterion 5: Study controls for age/gender  
Criterion 6: Study controls for any additional factor  
Criterion 7: Ascertainment of exposure  
Criterion 8: Same method of ascertainment for cases and controls  
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Table 3. Evidence table of the included studies 
 
References  Sample Inclusion criteria  Mean age 
(y; M ± SD) 
Assessment regarding CH Results RAP ↔ 
CON 
Alfven et al. 
(1993) 
49 RAP 
50 CON 
(Total: 69♂, 
71♀) 
RAP: pain during >3 months, 
at least1x/month 
CON: no pain symptoms 
11 
 
Algometer: PPT              
                                                         
m. temporalis, m. trapezius, m. 
subclavius, pectoralis major (lateral 
insertion), m. rectus abdominus (near 
umbilicus), m. quadriceps 
RAP: ↓ PPTs 
(p<0.05)* for all 
muscles except m. 
quadriceps (p=0.22) 
Duarte et al. 
(2000) 
100 RAP 
(45♂,55♀) 
100 CON 
(45♂,55♀) 
RAP: history of pain, at least 
lasting 1year 
CON: no previous history of 
recurrent or chronic pain 
RAP: 9.2 
CON: 9.0 
 
Algometer: PPT      
                                                                    
m. trapezius, m. deltoideus, 
supraspinous muscles, nine areas of the 
abdominal wall, median part of tibias 
RAP: ↓ PPTs 
(p=0.0000)* for all 
body regions 
 
Hermann et 
al. (2008) 
14 RAP  
(6♂,8♀) 
15 CON 
(7♂,8♀) 
RAP: modified Apley-
criteria 
CON: pain episode <1/month 
RAP: 12.1 
± 1.7 
CON: 12.3 
± 1.5 
Impact stimulating device: PPT     
                                           
pad of the distal phalanx of the left 
finger     
                                                
EEG: AEP, SEP      
                                                                            
forehead, right eye, right and left outer 
canthi of eyes 
RAP: ↑ P3 
component for non- 
and painful stimuli 
(p=0.002)*, 
↑ P3 amplitude for 
non- and painful 
stimuli (p=0.006 
and p=0.002)*, 
↓ P3 latency for 
non- and painful 
stimuli (p=0.001)* 
Zohsel et al. 
(2008) 
20 RAP 
(9♂,11♀) 
RAP: Apley- criteria, Rome 
III-criteria, VAS >3, pain 
during >3 months, at least 
RAP: 10.7 
± 1.7  
QST: HPT, TPS, MPT, MPS      
                                     
RAP: ↑ TPS 
(p<0.05)* at the 
thenar, 
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23 CON 
(13♂,10♀) 
2x/month  
CON: pain episode <1/month 
CON: 11.0 
± 1.5 
 
m. abdominus near umbilicus, thenar 
eminence nondominant hand     
↓ MPS (p=0.05)* at 
the thenar  
 
 
 
References  Sample Inclusion criteria  Mean age 
(y; M ± SD) 
Assessment regarding CH Results JIA ↔ 
CON 
Cornelissen et 
al. (2014) 
 
60 JIA 
(16♂,44♀) 
92 US CON 
(46♂,46♀) 
151 EU CON 
(75♂,76♀) 
 
JIA: clear diagnosis of JIA 
US CON: healthy children, 
no neurological disorders 
EU CON: healthy children  
 
JIA: 13.0 
US CON: 
13.0 
EU CON: 
11.0 
 
QST: MDT, VDT, CDT, CPT, HPT, 
MPT, Algometer: PPT  
 
affected joint, contralateral thenar 
eminence 
 
JIA: ↓ PPT vs. EU 
CON (p<0.001)* at 
thenar eminence, 
↓CPT vs. EU CON 
(p<0.01)*, vs. US 
CON (p<0.001)* at 
thenar eminence, 
↓HPT vs. EU CON 
(p<0.05), vs. US 
CON (p<0.001)* at 
thenar eminence  
Hogeweg et 
al. (1994) 
 
33 JIA 
(11♂,22♀) 
69 CON 
(33♂,36♀) 
 
JIA: EULAR-criteria 
CON: healthy children  
 
JIA:  
♂11.3 ± 1.5  
♀12.1 ± 2.1 
CON: 11.5 
± 3.1  
Algometer: PPT                                                                          
 
joints capsules of knees, ankles, soft 
paravertebral tissues 
 
JIA: ↓ PPT 
(p<0.01)* at all 
regions 
 
Hogeweg et 
al. (1995) 
 
57 JIA 
(18♂,39♀) 
69 CON 
(33♂,36♀) 
 
JIA: EULAR-criteria 
CON: healthy children  
 
JIA:  
♂12.2 ± 2.6  
♀11.8 ± 3.2  
CON: 11.5 
± 3.1  
Algometer: PPT        
                                                                  
joints capsules of wrists, elbows, 
knees, ankles, paravertebral soft tissues 
 
JIA: ↓ PPT 
(p<0.001)* at all 
regions  
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Leegaard et 
al. (2013) 
 
85 JIA 
(56♂,42♀) 
91 CON 
(36♂,55♀) 
JIA: ILAR-criteria 
CON: no comorbidity 
associated with pain 
JIA: 11.9 ± 
1.8  
CON: 12.2 
± 1.9  
Algometer: PPT  
                                                                      
17 symmetric anatomically predefined 
joint-related or bone-related areas 
JIA: ↓ total mean 
PPT (p<0.001)* 
 
References  Sample Inclusion criteria  Mean age 
(y; M ± SD) 
Assessment regarding CH Results MIG ↔ 
CON 
Zohsel et al. 
(2006) 
 
25 MIG 
(14♂,11♀) 
28 CON 
(12♂,16♀) 
MIG: IHS-criteria adapted 
for pediatric MIG 
CON: pain episode <1/month 
 
MIG: 11.0 
± 1.8  
CON: 11.0 
± 1.8  
QST: HPT, TPS, MPT, MPS    
                                                
trigeminal and thenar sites 
 
MIG: ↓ MPT 
(p<0.05)* at both 
trigeminal and 
thenar site  
Zohsel et al. 
(2008) 
 
16 MIG 
(8♂,7♀) 
15 CON 
(7♂,8♀) 
 
MIG: IHS-criteria adapted 
for pediatric MIG 
CON: pain episode <1/month 
 
MIG: 12.0 
± 1.5  
CON: 12.3 
± 1.5  
 
Impact stimulating device: PPT    
                                          
pad of the distal phalanx of the left 
finger  
                                                  
EEG: AEP, SEP     
                                                                     
forehead, right eye, right and left outer 
canthi of eyes                                                                         
 
MIG: ↑ P3 
component for non- 
and painful stimuli 
(p<0.05)*, 
↑ P3 amplitude for 
non- and painful 
stimuli (p<0.001)*, 
↓ P3 latency for 
painful stimuli
(p<0.001)* 
References  Sample Inclusion criteria  Mean age 
(y; M ± SD) 
Assessment regarding CH Results TMD ↔ 
CON 
Jedel et al. 
(2007) 
 
21 TMD 
(6♂,15♀) 
21 CON 
(6♂,15♀) 
 
TMD: >1/week TMD pain, 
during >3months 
CON: no JIA, Ehles Danlos 
syndrome, myositis 
ossificans, diabetes, CTTH, 
MIG, TMD 
TMD: 16 
CON: 16 
 
Pain matcher: PT   
                                                                        
between thumb and index finger left 
hand 
 
TMD: no 
significantly ↓ mean 
PT  
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References  Sample Inclusion criteria  Mean age 
(y; M ± SD) 
Assessment regarding CH Results FM/JIA ↔ 
CON 
Reid et al.    
(1997) 
 
15 FM 
(2♂,13♀) 
15 JRA 
(2♂,13♀) 
15 CON 
(2♂,13♀) 
 
FM: diagnosed within 
previous 2y 
JIA: polyarticular or systemic 
onset  
CON: healthy, no organic 
underlying organic illness 
 
 
FM: 14.5 ± 
1.88  
JRA: 14.5 ± 
1.95  
CON: 14.6 
± 1.89  
Algometer: PPT (tender and control 
points), PPT2 (control points)   
                                                   
right occiput, left and right trapezius, 
right supraspinatus, right lateral 
condyle, right greater trochanter, left 
and right knee, right low cervical 
 
FM: ↓ mean PPT 
(p<0.05)* at tender 
points,  
↓ mean PPT2 
(p<0.05)*at control 
points 
 
RAP: recurrent abdominal pain, CON: Control group, y: Year, m.: Musculus, SD: Standard deviation, PPT: Pressure pain threshold, M: mean, 
EEG: Electroencephalography, AEP: Auditory Evoked Potentials, SEP: Somatosensory evoked potentials, VAS: Visual analogue scale, QST: 
Quantitative sensory testing, HPT: Heat pain threshold, TPS: Thermal perceptual sensitization, MPT: Mechanical pain threshold, MPS: 
Mechanical perceptual sensitization, JIA: Juvenile idiopathic arthritis, US: United States, EU: Europe, MDT: Mechanical detection threshold, 
VDT: Vibration detection threshold, CPT: Cold pain threshold, EULAR: European league against rheumatism, ILAR: International league of 
associations for rheumatology, MIG: Migraine, CH: Central hyperexcitability, IHS: International headache society, TMD: Temporomandibular 
disorder, CTTD: Chronic tension-type headache, PT1: Pain threshold, FM: Fibromyalgia, PT2: Pain tolerance, * Significance level p<0.05 
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